KRYS position history
The shares of Krystal Biotech (KRYS) that TORRAY INVESTMENT PARTNERS LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 11,574 shares, $1.6M, 0.23% of portfolio, New
- 2025 Q3: 11,901 shares, $2.1M, 0.29% of portfolio, Add +2.8%
- 2025 Q4: 11,985 shares, $3M, 0.42% of portfolio, Add +0.7%
- 2026 Q1: 12,032 shares, $3.1M, 0.46% of portfolio, Add +0.4%
- 2026 Q2: 12,156 shares, $4.5M, 0.61% of portfolio, Add +1.0%
- 2026 Q3: 8,370 shares, $2.8M, 0.37% of portfolio, Reduce −31.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|